Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$748K Buy
5,822
+202
+4% +$23.6K 0.28% 62
2026
Q1
$676K Buy
5,620
+401
+8% +$46.3K 0.28% 62
2025
Q4
$549K Sell
5,219
-996
-16% -$93.5K 0.22% 74
2025
Q3
$522K Sell
6,215
-107
-2% -$8.81K 0.21% 83
2025
Q2
$500K Buy
6,322
+106
+2% +$8.43K 0.18% 72
2025
Q1
$558K Buy
6,216
+104
+2% +$9.71K 0.2% 60
2024
Q4
$608K Buy
6,112
+1
+0% +$103 0.27% 59
2024
Q3
$694K Buy
6,111
+1,402
+30% +$167K 0.31% 53
2024
Q2
$583K Buy
4,709
+103
+2% +$13.3K 0.28% 58
2024
Q1
$608K Sell
4,606
-898
-16% -$111K 0.3% 52
2023
Q4
$600K Sell
5,504
-97
-2% -$10.1K 0.31% 52
2023
Q3
$577K Buy
5,601
+201
+4% +$21.7K 0.34% 54
2023
Q2
$623K Buy
5,400
+800
+17% +$90.8K 0.36% 52
2023
Q1
$489K Buy
4,600
+500
+12% +$54K 0.28% 55
2022
Q4
$455K Sell
4,100
-300
-7% -$30.7K 0.31% 54
2022
Q3
$379K Buy
4,400
+200
+5% +$17.9K 0.27% 53
2022
Q2
$383K Buy
4,200
+200
+5% +$17.7K 0.26% 53
2022
Q1
$328K Buy
+4,000
New +$315K 0.22% 64

Other funds holding MRK

Beta Wealth Group's MRK Position: Q2 2026 in Review

Beta Wealth Group increased its Merck (MRK) stake by 3.6% in Q2 2026, buying an estimated $23.6K and bringing the position to 5,822 shares worth $748K. The position accounts for 0.28% of the portfolio, ranked #62.

Beta Wealth Group first reported a position in MRK in Q1 2022 and has held it in 18 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Beta Wealth Group held 5,822 shares of Merck worth $748K as of Q2 2026.
  • Beta Wealth Group bought 202 Merck shares in Q2 2026, an estimated $23.6K.
  • Merck made up 0.28% of Beta Wealth Group's portfolio in Q2 2026, its #62 holding.
  • Beta Wealth Group first reported a position in Merck in Q1 2022 and has held it in 18 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Beta Wealth Group's 13F filing for Q2 2026, filed 24 Jul 2026.